QSAR, docking studies of 1, 3-thiazinan-3-yl isonicotinamide derivatives for antitubercular activity TS Chitre, KD Asgaonkar, SM Patil, S Kumar, VM Khedkar, DR Garud Computational Biology and Chemistry 68, 211-218, 2017 | 18 | 2017 |
Novel 1, 3, 4-(thiadiazol-2-ylamino) methyl-5-(pyridin-4-yl)-1, 3, 4-oxadiazol-2-thiones: synthesis, docking and antimycobacterial testing TS Chitre, S Panda, SM Patil, AS Chothe, G Vignesh, MK Kathiravan Advances in Biological Chemistry 1 (02), 7, 2011 | 13 | 2011 |
Design, synthesis, docking and anti-mycobacterial activity of some novel thiouracil derivatives as thymidine monophoshate kinase (TMPKmt) inhibitors TS Chitre, KG Bothara, SM Patil, KD Asgaonkar, S Nagappa, ... Int. J. Res. Pharm. Biomed. Sci 2, 616-623, 2011 | 11 | 2011 |
Designing of thiazolidin-4-one pharmacophore using QSAR studies for anti-HIV activity TS Chitre, SM Patil, AG Sujalegaonkar, KD Asgaonkar Indian J. Pharm. Educ. Res 55 (2), 581-589, 2021 | 9 | 2021 |
QSAR Study and Evaluation of in vitro Anti-inflammatory activity for 1H-benzotriazol-1-yl {2-hydroxy-5-[(E) phenyldiazenyl] phenyl} methanone derivatives CM Jamkhandi, PS Kumbhar, JI Disouza, SM Patil European J Pharm Med Res 2 (4), 1004-1010, 2015 | 8 | 2015 |
Synthesis and Antitubercular activity of some substituted pyrimidine derivatives TS Chitre, MK Kathiravan, AS Chothe, VK Rakholiya, KD Asgaonkar, ... J. Pharm. Res 4, 1882-1883, 2011 | 8 | 2011 |
A review: Exploring synthetic schemes and structure-activity relationship (SAR) studies of mono-carbonyl curcumin analogues for cytotoxicity inhibitory anticancer activity SV Bhandari, P Kuthe, SM Patil, O Nagras, AP Sarkate Current Organic Synthesis 20 (8), 821-837, 2023 | 7 | 2023 |
A review: discovering 1, 3, 4-oxadiazole and chalcone nucleus for cytotoxicity/EGFR inhibitory anticancer activity S Patil, S Bhandari Mini Reviews in Medicinal Chemistry 22 (5), 805-820, 2022 | 7 | 2022 |
Comparative docking studies: a drug design tool for some pyrazine-thiazolidinone based derivatives for anti-HIV activity KD Asgaonkar, SM Patil, TS Chitre, VN Ghegade, SR Jadhav, SS Sande, ... Current Computer-Aided Drug Design 15 (3), 252-258, 2019 | 6 | 2019 |
Recent advances in cardiac troponin I based sensors for detection of human heart attack D Bhatnagar, S Patil, MP Singh, I Kaur, A Kumar Cellular and Molecular Biology 62 (3), 1000142, 2016 | 6 | 2016 |
2D and 3D QSAR of benzimidazole analogues as novel HIV-1 non nucleoside reverse transcriptase inhibitors S Patil, K Asgaonkar, T Chitre, V Bhat, S Ethape, A Sujalegaonkar, ... Indian Journal of Pharmaceutical Education and Research 51 (2 suppl), s122-s128, 2017 | 5 | 2017 |
In silico Studies, Synthesis and Antitubercular Activity of Some Novel Quinoline-Azitidinone Derivatives TS Chitre, KD Asgaonkar, AB Vikhe, SM Patil, DR Garud, VM Khedkar, ... Current Computer-Aided Drug Design 17 (1), 134-143, 2021 | 4 | 2021 |
Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives TS Chitre, SM Patil, AG Sujalegaonkar, KD Asgaonkar, VM Khedkar, ... Current computer-aided drug design 15 (5), 433-444, 2019 | 4 | 2019 |
A rational approach to anticancer drug design: 2D and 3D-QSAR, molecular docking and prediction of ADME properties using silico studies of thymidine phosphorylase inhibitors VV Raut, SV Bhandari, SM Patil, AP Sarkate Letters in Drug Design & Discovery 20 (2), 153-166, 2023 | 3 | 2023 |
Comparative study of various non-nucleoside reverse transcriptase inhibitors on different reverse transcriptase enzyme SM Patil, KD Asgaonkar, TS Chitre, A Kinikar, C Kharat, V Bhoirekar, ... Indian J Pharm Educ Res 51 (4s), s722-s728, 2017 | 3 | 2017 |
Exploring pyrimidine pharmacophore as thymidine monophosphate kinase inhibitors for antitubercular activity: a review T Sameer Chitre, K Dhirendra Asgaonkar, S Manoj Patil, ... Current Topics in Medicinal Chemistry 16 (28), 3211-3223, 2016 | 3 | 2016 |
Molecular Docking, Pharmacokinetic and Molecular Simulation Analysis of Novel Mono‐Carbonyl Curcumin Analogs as L858R/T790M/C797S Mutant EGFR Inhibitors SV Bhandari, PV Kuthe, SM Patil, OG Nagras, AP Sarkate, SY Chaudhari, ... Chemistry & Biodiversity 20 (11), e202301081, 2023 | 1 | 2023 |
Designing of Trifluoromethyl Substituted Pyrimidine Pharmacophore for Antiprostate Activity through a Collective Computational Approach TC Kalyani Asgaonkar, Sushruti Tanksali, Kshitija Abhang, Krishna Shevate ... Ind. J. Pharm. Edu. Res 57 (3), 827-837, 2023 | 1* | 2023 |
Optimization of Pharmacophore of Novel Hybrid Nucleus of 1,3,4-oxadiazole-chalcone Using Literature Findings and In-silico Approach as EGFR Inhibitor SMPSV Bhandari Letters in Drug Design & Discovery 20 (6), 779 - 791, 2022 | 1* | 2022 |
QSAR tool for optimization of nitrobenzamide pharmacophore for antitubercular activity KD Asgaonkar, SM Patil, TS Chitre, SD Wani, MT Singh Bulletin of the Karaganda University 105 (1), 60-68, 2022 | 1 | 2022 |